GDRX — Goodrx Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $1.68bn
- $1.73bn
- $792.32m
- 98
- 46
- 35
- 62
Annual cashflow statement for Goodrx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -294 | -25.3 | -32.8 | -8.87 | 16.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 450 | 168 | 146 | 127 | 108 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -32.5 | -11.8 | -20.3 | -21.9 | 2.09 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 131 | 179 | 147 | 138 | 184 |
| Capital Expenditures | -35.8 | -34.5 | -55.2 | -55.8 | -70.3 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -55.8 | -144 | -155 | 0 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -91.6 | -179 | -210 | -55.8 | -70.3 |
| Financing Cash Flow Items | 15 | -58.5 | -20.6 | -64.1 | -30.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 906 | -30.5 | -120 | -167 | -337 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 946 | -30.5 | -184 | -84.9 | -224 |